News

When leaders at Methodist Le Bonheur Healthcare (MLH), a not-for-profit health system based in Memphis, Tenn., saw the opportunity to standardize their suite of diagnostic imaging solutions, they capitalized on it. The seven-hospital system will deploy McKesson’s portfolio of enterprise medical imaging products across its various facilities to help improve physician collaboration, streamline data management and simplify its imaging archive process with a single point of access.

Home September 27, 2013
Home
News

Patient enrollment has been initiated in a post-market registry for the COMBO Dual Therapy Stent to evaluate its long-term safety and performance in routine clinical practice. The prospective, multicenter, all-comers REMEDEE Registry (Multicenter, Prospective, Clinical Outcomes After Deployment of the Abluminal Sirolimus Coated Bio-Engineered Stent (Combo Bio-Engineered Sirolimus Eluting Stent) Post Market Registry) will enroll 1,000 patients at nine European sites. More than 100 patients have already been enrolled.

Home September 27, 2013
Home
News

JenaValve Technology, Inc. announced that it has raised $62.5 million in a Series C venture round.

Home September 27, 2013
Home
News

Rox Medical has crossed the halfway point in the CONTROL-HTN international, multi-center, randomized controlled hypertension trial. The milestone was met with the enrollment of the first patient from Prof. Markus van der Giet and Prof. Walter Zidek of the Charite Hospital, Benjamin Franklin Campus, Berlin. The CONTROL-HTN trial is evaluating the Rox Flow procedure — creating a small connection between artery and vein in the upper leg - for the treatment of resistant hypertension.

Home September 27, 2013
Home
Technology

Parker Laboratories is introducing three, completely redesigned Thermasonic Gel Warmers at RSNA 2013. These include a single bottle gel warmer, a three-bottle gel warmer with preset temperature options and LED indicators, and a three-bottle gel warmer with LCD readout and temperature adjustment in one degree increments, in either Fahrenheit or Celsius.

Home September 27, 2013
Home
FDA regulates apps, mobile devices
Feature | Dave Fornell

In an effort to guide regulation of mobile medical apps, the U.S. Food and Drug Administration (FDA) issued a final guidance document for developers of mobile medical apps.

Home September 26, 2013
Home
Medicare Expenses Growth Heart Attack Patients 1998 2008
Feature

Medicare expenses for patients with acute myocardial infarction (AMI, heart attack) increased substantially between 1998 and 2008, with much of the increase coming in expenses 31 days or more after the patient was hospitalized, according to a study published by JAMA Internal Medicine, a JAMA Network publication.

Home September 26, 2013
Home
Icahn School of Medicine at Mount Sinai PARIS Study Antiplatelet Therapy PCI
Feature

Lead study investigators from Icahn School of Medicine at Mount Sinai presented their Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients (PARIS) study findings at the ESC Congress 2013 in Amsterdam organized by the European Society of Cardiology. Their new study results show among patients undergoing percutaneous coronary intervention (PCI) with stents, the risk of cardiovascular complications after stopping dual antiplatelet therapy (DAPT) is highly variable depending on the context, and some patients experience no complications at all.

Home September 26, 2013
Home
News

Siemens’ PETNET Solutions has announced a three-year agreement with The US Oncology Network to supply its entire portfolio of Food and Drug Administration (FDA)-approved positron emission tomography (PET) radiopharmaceutical agents at each of PETNET Solutions’ current Good Manufacturing Practices (cGMP)-certified locations throughout the United States.

Home September 26, 2013
Home
News

Biotronik announced the highly-anticipated results of the Reform study. The study demonstrates that ICD (implantable cardioverter-defibrillator) patients with Biotronik's Home Monitoring can enjoy a reduction in follow-up visits by 58 percent. This in turn leads to patients reporting enhanced quality of life.

Home September 26, 2013
Home
News

In 1988, the first Transcatheter Cardiovascular Therapeutics conference was held with less than 200 attendees in the basement of the Omni Shoreham Hotel in Washington, DC. The first meeting, a forum where physicians came to exchange ideas and compare emerging technologies, featured a single live case transmitted from Georgetown University School of Medicine.

Home September 26, 2013
Home
Feature

The U.S. Food and Drug Administration (FDA) announced a final rule for the unique device identification system (UDI) that, once implemented, will provide a consistent way to identify medical devices.

Home September 25, 2013
Home
News

A new study of patients who died of sudden cardiac arrest, a usually fatal condition that causes the heart to stop beating, shows the majority who qualified to receive potentially lifesaving treatment did not receive it.

Home September 25, 2013
Home
Technology

Physio-Control launched its comprehensive solution designed to improve cardiac resuscitation in hospitals. The CodeManagement Module, which adds capnography and wireless data capabilities to the Lifepak 20/20e defibrillator/monitor platform, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in August and achieved the CE mark for commercialization worldwide in April.

Home September 25, 2013
Home
News

Researchers have determined that fingerstick cardiac troponin I assay testing using the point-of-care i-STAT device is not accurate enough to determine the exact troponin level without the application of a corrective term.

Home September 25, 2013
Home
Subscribe Now